WIPO releases negotiating November 20th text: Treaty for the Blind

On Wednesday, 21 November 2012, the plenary of the 25th Standing Committee on Copyright and Related Rights (SCCR) resumed at 10:30 AM. After the plenary, the an ambassador-level meeting of the African Group will be held. The informals are expected to take place between 2PM to 9PM.

The November 20th text is reproduced below:

Text agreed on November 20, 2012.

PREAMBLE

(Twelfth)

Continue Reading

Uncategorized

European Union announces its mandate to negotiate a binding Treaty for the Blind

On 19 November 2012, the European Union announced to WIPO’s Standing Committee on Copyright and Related Rights (SCCR) that it now had the mandate to “negotiate the conclusion conclusion of an instrument including a binding treaty” for the blind.

EUROPEAN UNION

Statement by the European Union and its Member States 25th Session of WIPO Standing Committee on Copyright and Related Rights

Mr Chairman,

Continue Reading

Uncategorized

Mark Dybul emerges victorious in Global Fund leadership race defeating candidates from Canada, France and UK

It was a papal conclave save for the plume of white smoke. At 17h04 on Thursday, 15 November 2012, the board of the Global Fund to Fight AIDS, Tuberculosis and Malaria announced that Dr Mark Dybul would be the organization’s next Executive Director following a process marked by opacity and secrecy that would do the Vatican proud. Dybul (former United States Global AIDS Coordinator) beat a field of three other candidates that included, Monique Barbut (France), Robert Greenhill (Canada) and Barbara Stocking (United Kingdom of Great Britain and Northern Ireland). Continue Reading

Uncategorized

Pay-for-Delay Circuit Split Continues; 31 States File Amicus Brief Arguing Pay-For-Delay is Presumptively Unlawful

Earlier this year, in the case In re K-Dur, the Court of Appeals for the Third Circuit found that reverse settlement agreements, also known as “pay-for delay” arrangements, were prima facie evidence of anticompetitive behavior. The court noted that the presumption that such payments are unreasonable restraints of trade can be rebutted by a showing that the payment either offered a pro-competitive benefit or that the payment was for a purpose other than delayed entry into the market of generics. Continue Reading

Uncategorized